LEGN
Legend Biotech Corp ADR
3월 13일 4:00 PM ET (한국 3/14 05:00)
$18.75
-0.30 ▼ -1.57%
🌙 3월 13일 7:02 PM ET (한국 3/14 08:02)
$18.58
-0.17 ▼ -0.91%
| Index | - | P/E | - | EPS (ttm) | -1.62 | Insider Own | 3.66% | Shs Outstand | 0.18B | Perf Week | -1.16% |
| Market Cap | 3.47B | Forward P/E | 18.95 | EPS next Y | 293.69% | Insider Trans | - | Shs Float | 0.18B | Perf Month | 1.13% |
| Enterprise Value | 2.93B | PEG | - | EPS next Q | 0.01 | Inst Own | 44.96% | Short Float | 11.25% | Perf Quarter | -19.73% |
| Income | -0.30B | P/S | 3.36 | EPS this Y | 131.03% | Inst Trans | 1.38% | Short Ratio | 8.31 | Perf Half Y | -44.58% |
| Sales | 1.03B | P/B | 3.46 | EPS next 5Y | - | ROA | -17.48% | Short Interest | 20.05M | Perf YTD | -13.75% |
| Book/sh | 5.42 | P/C | 3.66 | EPS past 3/5Y | 16.8% 6.49% | ROE | -29.14% | 52W High | -58.61% ($45.30) | Perf Year | -50.72% |
| Cash/sh | 5.13 | P/FCF | - | Sales past 3/5Y | 106.67% 68.87% | ROIC | -27.32% | 52W Low | 15.46% ($16.24) | Perf 3Y | -58.57% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -66.81% | Gross Margin | 57.5% | Volatility(W/M) | 5.46% 4.97% | Perf 5Y | -25.98% |
| Dividend TTM | - | EV/Sales | 2.84 | Sales Y/Y TTM | 64.66% | Oper. Margin | -13.17% | ATR (14) | 1 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.91 | EPS Q/Q | -217.32% | Profit Margin | -28.84% | RSI (14) | 48.26 | Recom | 1.33 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.96 | Sales Q/Q | 65.57% | SMA20 | -0.11% ($18.77) | Beta | 0.06 | Target Price | $57.4 |
| Payout | - | Debt/Eq | 0.41 | Earnings | 3000000 | SMA50 | -3.54% ($19.44) | Rel Volume | 0.59 | Prev Close | $19.05 |
| Employees | 2900 | LT Debt/Eq | 0.09 | EPS/Sales Surpr. | -16100% -0.47% | SMA200 | -36.61% ($29.58) | Avg Volume(3M) | 2.41M | Price | $18.75 |
| IPO | 2020/6/5 | Option/Short | Yes/Yes | Trades | 11896 | Volume | 1,418,116 | Change | -1.57% |
뉴스 로딩 중...